Lithium Tablets

Intended to target mood instability and developed to manage the symptoms of bipolar disorder effectively.

Strengths: 300mg

Medicine details

Alternative names

Liskonum; Priadel

Therapeutic class

Mood Stabiliser

Pharmacological class

Inorganic Cation

Contraindications

cardiac disease; severe renal impairment; untreated hypothyroidism

Minor side effects

tremor; increased thirst; polyuria

Moderate side effects

hypothyroidism; weight gain; diarrhoea

Dosage forms

Prolonged-release tablet

Administration route

Oral use

Prescription status

POM

Manufacturer

Essential Pharma

Onset Time

1–2 weeks

Duration

Continuous

Storage instructions

Store below 25°C in a dry place.

Drug interactions

diuretics; nsaids; ace inhibitors; fluoxetine

Age restrictions

Use with caution in elderly patients.

Precautions and warnings

maintain adequate fluid and salt intake; regular blood monitoring is essential for safety; avoid abrupt discontinuation

Serious side effects

lithium toxicity — requires immediate medical attention; nephrogenic diabetes insipidus — requires immediate medical attention

Patient summary

Intended to target mood instability and developed to manage the symptoms of bipolar disorder effectively.

Mechanism of action

Lithium helps balance neurotransmitters in the brain by modulating the release of serotonin and norepinephrine, effectively reducing the frequency and severity of manic and depressive episodes.

Pregnancy and breastfeeding

Pregnancy: Associated with risk of cardiac malformations; consult a specialist. Breastfeeding: Lithium is present in breast milk; generally advised against.

Lithium Tablets

Intended to target mood instability and developed to manage the symptoms of bipolar disorder effectively.

Editorial Notes

  • Active ingredient(s): Lithium
  • Listed indication(s): Bipolar Disorder, Recurrent Depressive Disorder

Available option

  • 180 tablets - 300 mg962-300-mg-11823